Segment Disclosures - Summary Information for the Reportable Segments (Details) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2022 USD ($)	Jun. 30, 2022 USD ($) property	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) property	Jun. 30, 2021 USD ($)
Segment Disclosure
Number of facilities owned by unconsolidated joint venture | property		19		19
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		$ 517,932	$ 476,238	$ 1,016,304	$ 931,514
Government grant income		209	87	6,762	1,397
Less: Interest income		(5,493)	(16,108)	(10,987)	(25,121)
Healthpeak’s share of unconsolidated joint venture total revenues		20,243	21,277	40,451	44,570
Healthpeak’s share of unconsolidated joint venture government grant income			583	648	1,009
Noncontrolling interests’ share of consolidated joint venture total revenues		(9,005)	(8,900)	(17,882)	(17,891)
Operating expenses		(215,044)	(190,132)	(422,291)	(371,893)
Healthpeak’s share of unconsolidated joint venture operating expenses		(14,934)	(15,404)	(29,771)	(33,463)
Noncontrolling interests’ share of consolidated joint venture operating expenses		2,745	2,573	5,366	5,097
Adjustments to NOI		(24,539)	(13,170)	(42,206)	(26,771)
Adjusted NOI		272,114	257,044	546,394	508,448
Plus: Adjustments to NOI		24,539	13,170	42,206	26,771
Interest income		5,493	16,108	10,987	25,121
Interest expense		(41,867)	(38,681)	(79,453)	(85,524)
Depreciation and amortization		(180,489)	(171,459)	(358,222)	(328,997)
General and administrative		(24,781)	(24,088)	(48,612)	(48,990)
Transaction costs		(612)	(619)	(908)	(1,417)
Impairments and loan loss reserves		(139)	(931)	(271)	(4,173)
Gain (loss) on sales of real estate, net		10,340	175,238	14,196	175,238
Gain (loss) on debt extinguishments		0	(60,865)	0	(225,157)
Other income (expense), net		2,861	1,734	21,177	3,934
Less: Government grant income		(209)	(87)	(6,762)	(1,397)
Less: Healthpeak’s share of unconsolidated joint venture NOI		(5,309)	(6,456)	(11,328)	(12,116)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		6,260	6,327	12,516	12,794
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		68,201	166,435	141,920	44,535
Income tax benefit (expense)		718	763	(59)	755
Equity income (loss) from unconsolidated joint ventures		382	867	2,466	2,190
Income (loss) from continuing operations		69,301	168,065	144,327	47,480
Income (loss) from discontinued operations		2,992	113,960	3,309	383,968
Net income (loss)		72,293	282,025	147,636	431,448
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		0	0	0	0
Government grant income		0	0	0	0
Less: Interest income		0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues		0	0	0	0
Healthpeak’s share of unconsolidated joint venture government grant income			0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues		0	0	0	0
Operating expenses		0	0	0	0
Healthpeak’s share of unconsolidated joint venture operating expenses		0	0	0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses		0	0	0	0
Adjustments to NOI		0	0	0	0
Adjusted NOI		0	0	0	0
Plus: Adjustments to NOI		0	0	0	0
Interest income		0	0	0	0
Interest expense		(38,061)	(35,923)	(72,746)	(80,651)
Depreciation and amortization		0	0	0	0
General and administrative		(24,781)	(24,088)	(48,612)	(48,990)
Transaction costs		(443)	0	(443)	0
Impairments and loan loss reserves		0	0	0	0
Gain (loss) on sales of real estate, net		0	0	0	0
Gain (loss) on debt extinguishments			(60,865)		(225,157)
Other income (expense), net		920	1,716	1,828	3,532
Less: Government grant income		0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		0	0	0	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		0	0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		(62,365)	(119,160)	(119,973)	(351,266)
Income tax benefit (expense)		718	763	(59)	755
Equity income (loss) from unconsolidated joint ventures		0	0	0	0
Income (loss) from continuing operations		(61,647)	(118,397)	(120,032)	(350,511)
Income (loss) from discontinued operations		2,992	113,960	3,309	383,968
Net income (loss)		(58,655)	(4,437)	(116,723)	33,457
Life Science
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	$ 4,000
Life Science | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		207,771	177,527	401,826	347,461
Government grant income		0	0	0	0
Less: Interest income		0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues		1,267	1,412	2,698	2,749
Healthpeak’s share of unconsolidated joint venture government grant income			0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues		(62)	(75)	(119)	(140)
Operating expenses		(49,446)	(40,724)	(97,635)	(80,185)
Healthpeak’s share of unconsolidated joint venture operating expenses		(483)	(428)	(966)	(853)
Noncontrolling interests’ share of consolidated joint venture operating expenses		19	21	38	41
Adjustments to NOI		(21,644)	(12,366)	(35,756)	(24,176)
Adjusted NOI		137,422	125,367	270,086	244,897
Plus: Adjustments to NOI		21,644	12,366	35,756	24,176
Interest income		0	0	0	0
Interest expense		0	(48)	0	(150)
Depreciation and amortization		(79,673)	(76,955)	(157,811)	(145,388)
General and administrative		0	0	0	0
Transaction costs		(35)	21	(327)	(11)
Impairments and loan loss reserves		0	0	0	0
Gain (loss) on sales of real estate, net		0	0	3,856	0
Gain (loss) on debt extinguishments			0		0
Other income (expense), net		29	28	20	33
Less: Government grant income		0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		(784)	(984)	(1,732)	(1,896)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		43	54	81	99
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		78,646	59,849	149,929	121,760
Income tax benefit (expense)		0	0	0	0
Equity income (loss) from unconsolidated joint ventures		148	111	1,114	18
Income (loss) from continuing operations		78,794	59,960	151,043	121,778
Income (loss) from discontinued operations		0	0	0	0
Net income (loss)		78,794	59,960	151,043	121,778
Medical Office
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		10,000
Medical Office | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		179,308	165,295	356,571	325,496
Government grant income		0	0	0	0
Less: Interest income		0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues		761	710	1,493	1,425
Healthpeak’s share of unconsolidated joint venture government grant income			0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues		(8,943)	(8,825)	(17,763)	(17,751)
Operating expenses		(63,321)	(54,648)	(124,491)	(105,769)
Healthpeak’s share of unconsolidated joint venture operating expenses		(301)	(317)	(600)	(611)
Noncontrolling interests’ share of consolidated joint venture operating expenses		2,726	2,552	5,328	5,056
Adjustments to NOI		(2,949)	(2,003)	(6,495)	(3,926)
Adjusted NOI		107,281	102,764	214,043	203,920
Plus: Adjustments to NOI		2,949	2,003	6,495	3,926
Interest income		0	0	0	0
Interest expense		(1,930)	(786)	(2,966)	(881)
Depreciation and amortization		(68,873)	(63,371)	(136,646)	(121,326)
General and administrative		0	0	0	0
Transaction costs		(70)	35	(74)	(295)
Impairments and loan loss reserves		0	0	0	0
Gain (loss) on sales of real estate, net		10,340	175,238	10,340	175,238
Gain (loss) on debt extinguishments			0		0
Other income (expense), net		1,264	(175)	12,201	(2,454)
Less: Government grant income		0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		(460)	(393)	(893)	(814)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		6,217	6,273	12,435	12,695
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		56,718	221,588	114,935	270,009
Income tax benefit (expense)		0	0	0	0
Equity income (loss) from unconsolidated joint ventures		211	137	411	328
Income (loss) from continuing operations		56,929	221,725	115,346	270,337
Income (loss) from discontinued operations		0	0	0	0
Net income (loss)		56,929	221,725	115,346	270,337
CCRC | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		125,360	117,308	246,920	233,436
Government grant income		209	87	6,762	1,397
Less: Interest income		0	0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues		0	2,415	0	6,903
Healthpeak’s share of unconsolidated joint venture government grant income			0	333	199
Noncontrolling interests’ share of consolidated joint venture total revenues		0	0	0	0
Operating expenses		(102,277)	(94,760)	(200,165)	(185,939)
Healthpeak’s share of unconsolidated joint venture operating expenses		0	(2,208)	0	(6,953)
Noncontrolling interests’ share of consolidated joint venture operating expenses		0	0	0	0
Adjustments to NOI		0	1,226	0	1,246
Adjusted NOI		23,292	24,068	53,850	50,289
Plus: Adjustments to NOI		0	(1,226)	0	(1,246)
Interest income		0	0	0	0
Interest expense		(1,876)	(1,924)	(3,741)	(3,842)
Depreciation and amortization		(31,943)	(31,133)	(63,765)	(62,283)
General and administrative		0	0	0	0
Transaction costs		(64)	(657)	(64)	(1,090)
Impairments and loan loss reserves		0	0	0	0
Gain (loss) on sales of real estate, net		0	0	0	0
Gain (loss) on debt extinguishments			0		0
Other income (expense), net		630	165	7,141	2,341
Less: Government grant income		(209)	(87)	(6,762)	(1,397)
Less: Healthpeak’s share of unconsolidated joint venture NOI		0	(207)	(333)	(149)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		0	0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		(10,170)	(11,001)	(13,674)	(17,377)
Income tax benefit (expense)		0	0	0	0
Equity income (loss) from unconsolidated joint ventures		0	639	539	639
Income (loss) from continuing operations		(10,170)	(10,362)	(13,135)	(16,738)
Income (loss) from discontinued operations		0	0	0	0
Net income (loss)		(10,170)	(10,362)	(13,135)	(16,738)
Other Non-reportable | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues		5,493	16,108	10,987	25,121
Government grant income		0	0	0	0
Less: Interest income		(5,493)	(16,108)	(10,987)	(25,121)
Healthpeak’s share of unconsolidated joint venture total revenues		18,215	16,740	36,260	33,493
Healthpeak’s share of unconsolidated joint venture government grant income			583	315	810
Noncontrolling interests’ share of consolidated joint venture total revenues		0	0	0	0
Operating expenses		0	0	0	0
Healthpeak’s share of unconsolidated joint venture operating expenses		(14,150)	(12,451)	(28,205)	(25,046)
Noncontrolling interests’ share of consolidated joint venture operating expenses		0	0	0	0
Adjustments to NOI		54	(27)	45	85
Adjusted NOI		4,119	4,845	8,415	9,342
Plus: Adjustments to NOI		(54)	27	(45)	(85)
Interest income		5,493	16,108	10,987	25,121
Interest expense		0	0	0	0
Depreciation and amortization		0	0	0	0
General and administrative		0	0	0	0
Transaction costs		0	(18)	0	(21)
Impairments and loan loss reserves		(139)	(931)	(271)	(4,173)
Gain (loss) on sales of real estate, net		0	0	0	0
Gain (loss) on debt extinguishments			0		0
Other income (expense), net		18	0	(13)	482
Less: Government grant income		0	0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI		(4,065)	(4,872)	(8,370)	(9,257)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI		0	0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures		5,372	15,159	10,703	21,409
Income tax benefit (expense)		0	0	0	0
Equity income (loss) from unconsolidated joint ventures		23	(20)	402	1,205
Income (loss) from continuing operations		5,395	15,139	11,105	22,614
Income (loss) from discontinued operations		0	0	0	0
Net income (loss)		$ 5,395	$ 15,139	$ 11,105	$ 22,614